Literature DB >> 19875159

Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer.

Geoffrey S Payne1, Maria Schmidt, Veronica A Morgan, Sharon Giles, Jane Bridges, Thomas Ind, Nandita M DeSouza.   

Abstract

OBJECTIVE: To establish whether ADC and total choline were significantly different between cervical tumors with different histological characteristics (type, degree of differentiation, presence or absence of lymphovascular invasion, lymph-node involvement) in order to establish their role as predictive biomarkers.
METHODS: 62 patients with stage 1 cervical cancer were scanned at 1.5 T. T2-weighted imaging (TR/TE=4500/80 ms), to identify tumor and normal cervix, was followed by diffusion-weighted imaging (TR/TE=2500/69 ms; 5 b-values 0, 100, 300, 500 and 800 s/mm(2)) and MR spectroscopic imaging (15 mm slice, 7.5 mm in-plane resolution, TR=888 ms). Regions of interest in normal cervix and tumor were drawn on apparent diffusion coefficient (ADC) maps by an expert observer with reference to the T2-weighted images. ADCs were calculated using a monoexponential fit of data from all b-values. MR spectra in voxels designated as tumor (>30% tumor) or non-tumor were quantified using LCModel and referenced to tissue water.
RESULTS: There was a statistically significant difference between the ADC of tumor regions (1117+/-183x10(-6) mm(2)/s) and of selected normal regions (1724+/-198x10(-6) mm(2)/s; p<0.001), and between tumors that were well/moderately differentiated (1196+/-181x10(-6) mm(2)/s) compared with those that were poorly differentiated (1038+/-153x10(-6) mm(2)/s; p=0.016). There was no significant difference between the ADCs of the tumors when separated by other characteristics (tumor type, lymphovascular invasion, lymph-node metastases), or between measured total choline in any of the groups.
CONCLUSION: ADCs are lower in cancer compared to normal cervical tissue, with degree of tumor differentiation contributing to this difference. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875159     DOI: 10.1016/j.ygyno.2009.09.044

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  29 in total

1.  Differentiation of benign and malignant uterine corpus tumors by using proton MR spectroscopy at 3T: preliminary study.

Authors:  Mayumi Takeuchi; Kenji Matsuzaki; Masafumi Harada
Journal:  Eur Radiol       Date:  2010-10-03       Impact factor: 5.315

2.  Preliminary observations and clinical value of N-acetyl resonances in ovarian tumours using in-vivo proton MR spectroscopy at 3T.

Authors:  Mayumi Takeuchi; Kenji Matsuzaki; Masafumi Harada
Journal:  Eur Radiol       Date:  2011-08-05       Impact factor: 5.315

Review 3.  Functional MRI and CT biomarkers in oncology.

Authors:  J M Winfield; G S Payne; N M deSouza
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-13       Impact factor: 9.236

4.  Value of diffusion-weighted imaging in predicting parametrial invasion in stage IA2-IIA cervical cancer.

Authors:  Jung Jae Park; Chan Kyo Kim; Sung Yoon Park; Byung Kwan Park; Bohyun Kim
Journal:  Eur Radiol       Date:  2014-02-13       Impact factor: 5.315

5.  Contribution of mono-exponential, bi-exponential and stretched exponential model-based diffusion-weighted MR imaging in the diagnosis and differentiation of uterine cervical carcinoma.

Authors:  Meng Lin; Xiaoduo Yu; Yan Chen; Han Ouyang; Bing Wu; Dandan Zheng; Chunwu Zhou
Journal:  Eur Radiol       Date:  2016-09-27       Impact factor: 5.315

Review 6.  Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer?

Authors:  Roberto García-Figueiras; Sandra Baleato-González; Anwar R Padhani; Laura Oleaga; Joan C Vilanova; Antonio Luna; Juan Carlos Cobas Gómez
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

7.  Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.

Authors:  Jennifer C Ho; Pamela K Allen; Priya R Bhosale; Gaiane M Rauch; Clifton D Fuller; Abdallah S R Mohamed; Michael Frumovitz; Anuja Jhingran; Ann H Klopp
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-11-17       Impact factor: 7.038

8.  Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.

Authors:  Gigin Lin; Lan-Yan Yang; Yu-Chun Lin; Yu-Ting Huang; Feng-Yuan Liu; Chun-Chieh Wang; Hsin-Ying Lu; Hsin-Ju Chiang; Yu-Ruei Chen; Ren-Chin Wu; Koon-Kwan Ng; Ji-Hong Hong; Tzu-Chen Yen; Chyong-Huey Lai
Journal:  Eur Radiol       Date:  2018-07-26       Impact factor: 5.315

9.  Preliminary observations and clinical value of lipid peak in high-grade uterine sarcomas using in vivo proton MR spectroscopy.

Authors:  Mayumi Takeuchi; Kenji Matsuzaki; Masafumi Harada
Journal:  Eur Radiol       Date:  2013-06-06       Impact factor: 5.315

10.  Evaluation of diffusion-weighted imaging (DWI) and MR spectroscopy (MRS) as early response biomarkers in cervical cancer patients.

Authors:  Stefania Rizzo; Valentina Buscarino; Daniela Origgi; Paul Summers; Sara Raimondi; Roberta Lazzari; Fabio Landoni; Massimo Bellomi
Journal:  Radiol Med       Date:  2016-07-02       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.